No abstract available
MeSH terms
-
Adolescent
-
Adult
-
Antiviral Agents*
-
Child
-
Cost-Benefit Analysis
-
Female
-
Genital Neoplasms, Male / prevention & control
-
Genital Neoplasms, Male / virology
-
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
-
Humans
-
Immunization / economics
-
Immunization / methods
-
Male
-
Papillomavirus Infections / economics
-
Papillomavirus Infections / prevention & control*
-
Papillomavirus Vaccines* / economics
-
Socioeconomic Factors
-
Young Adult
Substances
-
Antiviral Agents
-
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
-
Papillomavirus Vaccines
-
human papillomavirus vaccine, L1 type 16, 18